From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...
John Sacaria Thirusailam, once very active in life, was forced to leave his well-paid job at the age of 44 after being ...
Berlin, Germany, and Research Triangle Park, N.C., USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Not intended for UK MediaRegenerative Medicine ...
Researchers suggest drugs that prevent cholesterol from being converted to 24-OHC might therefore be an effective treatment for Parkinson's disease.
In a recent study, talk therapy in Parkinson’s disease led to significant improvement in patients' well-being, problems/symptoms, and functioning.
By combining advanced blood analysis with artificial intelligence, the test is able to identify early signs of Parkinson’s disease in individuals who have not yet shown clinical symptoms ...
From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, scientists were able to identify ...
AskBio’s gene therapy AB-1005 to treat Parkinson’s disease receives US FDA Regenerative Medicine Advanced Therapy designation: Berlin, Germany Thursday, February 20, 2025, 10: ...
The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients. Weekly injections of the GLP-1 receptor agonist exenatide (Byetta, ...
Procyclidine shows promise in reducing nicotine withdrawal symptoms, providing a potential new option for smoking cessation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results